These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 17009857

  • 1. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD, Huang L.
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [Abstract] [Full Text] [Related]

  • 2. Surface-modified LPD nanoparticles for tumor targeting.
    Li SD, Huang L.
    Ann N Y Acad Sci; 2006 Oct; 1082():1-8. PubMed ID: 17145918
    [Abstract] [Full Text] [Related]

  • 3. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.
    Biomacromolecules; 2009 Jan 12; 10(1):41-8. PubMed ID: 19072631
    [Abstract] [Full Text] [Related]

  • 4. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
    Mendonça LS, Firmino F, Moreira JN, Pedroso de Lima MC, Simões S.
    Bioconjug Chem; 2010 Jan 12; 21(1):157-68. PubMed ID: 20000596
    [Abstract] [Full Text] [Related]

  • 5. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.
    Eur J Pharm Biopharm; 2008 Nov 12; 70(3):718-25. PubMed ID: 18647651
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ, Marcucci G, Lee RJ.
    Anticancer Res; 2006 Nov 12; 26(2A):1049-56. PubMed ID: 16619505
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
    Fuessel S, Herrmann J, Ning S, Kotzsch M, Kraemer K, Schmidt U, Hakenberg OW, Wirth MP, Meye A.
    Cancer Lett; 2006 Feb 08; 232(2):243-54. PubMed ID: 16458121
    [Abstract] [Full Text] [Related]

  • 11. An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation.
    Huang Z, King MR.
    Gene Ther; 2009 Oct 08; 16(10):1271-82. PubMed ID: 19554031
    [Abstract] [Full Text] [Related]

  • 12. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
    Aukunuru JV, Ayalasomayajula SP, Kompella UB.
    J Pharm Pharmacol; 2003 Sep 08; 55(9):1199-206. PubMed ID: 14604462
    [Abstract] [Full Text] [Related]

  • 13. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK, Davaa E, Myung CS, Park JS.
    Int J Pharm; 2010 Jun 15; 392(1-2):141-7. PubMed ID: 20347025
    [Abstract] [Full Text] [Related]

  • 14. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P, Crielaard BJ, van Dommelen SM, van der Meel R, Storm G, Schiffelers RM.
    J Control Release; 2012 Jun 10; 160(2):211-6. PubMed ID: 21983283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK, Musyanovych A, Altvater M, Scheurich P, Pfizenmaier K, Landfester K, Kontermann RE.
    J Control Release; 2009 Jul 01; 137(1):69-77. PubMed ID: 19306900
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.